Risk factors for invasive fungal disease in critically ill adult patients: a systematic review

Abstract

IntroductionOver 5,000 cases of invasive Candida species infections occur in the United Kingdom each year, and around 40% of these cases occur in critical care units. Invasive fungal disease (IFD) in critically ill patients is associated with increased morbidity and mortality at a cost to both the individual and the National Health Service. In this paper, we report the results of a systematic review performed to identify and summarise the important risk factors derived from published multivariable analyses, risk prediction models and clinical decision rules for IFD in critically ill adult patients to inform the primary data collection for the Fungal Infection Risk Evaluation Study.MethodsAn internet search was performed to identify articles which investigated risk factors, risk prediction models or clinical decisions rules for IFD in critically ill adult patients. Eligible articles were identified in a staged process and were assessed by two investigators independently. The methodological quality of the reporting of the eligible articles was assessed using a set of questions addressing both general and statistical methodologies.ResultsThirteen articles met the inclusion criteria, of which eight articles examined risk factors, four developed a risk prediction model or clinical decision rule and one evaluated a clinical decision rule. Studies varied in terms of objectives, risk factors, definitions and outcomes. The following risk factors were found in multiple studies to be significantly associated with IFD: surgery, total parenteral nutrition, fungal colonisation, renal replacement therapy, infection and/or sepsis, mechanical ventilation, diabetes, and Acute Physiology and Chronic Health Evaluation II (APACHE II) or APACHE III score. Several other risk factors were also found to be statistically significant in single studies only. Risk factor selection process and modelling strategy also varied across studies, and sample sizes were inadequate for obtaining reliable estimates.ConclusionsThis review shows a number of risk factors to be significantly associated with the development of IFD in critically ill adults. Methodological limitations were identified in the design and conduct of studies in this area, and caution should be used in their interpretation.

Multicenter Study Evaluating the Vitek MS System for Identification of Medically Important Yeasts

“…s the number of patients with profound immunosuppression (such as those with solid-organ and hematopoietic stem cell transplants) continues to rise, the morbidity and mortality burdens attributed to invasive fungal infections are increasing (1)(2)(3)(4)(5)(6). In the case of invasive fungal infections, expedient identification of the offending organism is essential for optimal patient management and the best clinical outcomes.…”

Risk for Invasive Fungal Infections during Acute Myeloid Leukemia Induction Therapy: a True Association with Echinocandins?

“…It is likely that these patients were then started on ECs, potentially enriching the EC prophylaxis group with patients with baseline toxicities and greater comorbidities. Inability to tolerate oral medications, switching to EC prophylaxis due to toxicity, and liver disease are also likely surrogate markers for severity of illness, another predictor of IFIs (9,10). The lowest rate of IFI in this study was actually seen in the fluconazole group (Fig.…”

Invasive candidiasis in critical care setting, updated recommendations from “Invasive Fungal Infections-Clinical Forum”, Iran

“…According to the panel's opinion, LoS in the ICU and total days on mechanical ventilation, the presence of CVC/TPN, dialysis catheters, use of broad spectrum antibiotics, sepsis, presence of GI surgery, burn and high Acute Physiology and Chronic Health Evaluation II Score (> 16) [61] were considered as main risk factors justifying the empirical antifungal therapy against IC in febrile, non-neutropenic critically-ill patients admitted to the ICU.…”